Occurrence of mutations in the epidermal growth factor receptor gene in X-ray-induced rat lung tumors

Cancer Science

Volumn 99, Issue 2, 2008, Pages 241-245

  Kitahashi, Tsukasa ^a   Takahashi, Mami ^a   Yamada, Yutaka ^b   Oghiso, Yoichi ^c   Yokohira, Masanao ^d   Imaida, Katsumi ^d   Tsutsumi, Masahiro ^e   Takasuka, Nobuo ^a   Sugimura, Takashi ^a   Wakabayashi, Keiji ^a  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^b NATIONAL INSTITUTE OF RADIOLOGICAL SCIENCES   (Japan)

^c INSTITUTE FOR ENVIRONMENTAL SCIENCES   (Japan)

^d KAGAWA UNIVERSITY   (Japan)

^e Saiseikai Chuwa Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

2 AMINO 3,8 DIMETHYLIMIDAZO[4,5 F]QUINOXALINE; 4 (METHYLNITROSAMINO) 1 (3 PYRIDYL) 1 BUTANONE; ADENINE; BIS(2 HYDROXYPROPYL)NITROSAMINE; CYTOSINE; EPIDERMAL GROWTH FACTOR RECEPTOR; GUANINE; K RAS PROTEIN; TYROSINE; URETHAN;

AMINO ACID SUBSTITUTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHEMICAL CARCINOGENESIS; CODON; CONTROLLED STUDY; DNA EXTRACTION; EXON; FEMALE; GENE MUTATION; LUNG CANCER; LUNG CARCINOGENESIS; LUNG TUMOR; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RADIATION INJURY; RAT; SINGLE STRAND CONFORMATION POLYMORPHISM;

ANIMALS; BASE SEQUENCE; CARCINOGENS; EXONS; FEMALE; GENES, ERBB-1; GENES, RAS; LUNG NEOPLASMS; MICE; MICE, INBRED STRAINS; MOLECULAR SEQUENCE DATA; MUTATION; NEOPLASMS, RADIATION-INDUCED; NITROSAMINES; RATS; URETHANE; X-RAYS;

EID: 38949200943     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2008.00680.x     Document Type: Article

References (25)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Estimating the world cancer burden: Globocan 2000. Int J Cancer 2001; 94: 153-6.
2. Jemal A, Siegel R, Ward E et al. Cancer statistics, 2006. CA Cancer J Clin 2006; 56: 106-30.
3. Le Calvez F, Mukeria A, Hunt JD et al. TP53 and KRAS mutation load and types in lung cancers in relation to tobacco smoke: Distinct patterns in never, former, and current smokers. Cancer Res 2005; 65: 5076-83.
4. Subramanian J, Govindan R. Lung cancer in never smokers. J Clin Oncol 2007; 25: 561-70.
5. Sinha R, Kulldorff M, Swanson CA et al. Dietary heterocyclic amines and the risk of lung cancer among Missouri women. Cancer Res 2000; 60: 3753-6.
6. Sugimura T, Wakabayashi K, Nakagama H, Nagao M. Heterocyclic amines: Mutagens/carcinogens produced during cooking of meat and fish. Cancer Sci 2004; 95: 290-9.
7. Paez JG, Janne PA, Lee JC et al. EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy. Science 2004; 304: 1497-500.
8. Pao W, Miller V, Zakowski M et al. EGF receptor gene mutations are common in lung cancers from 'never smokers'and are associated with sensitivity of tumors to gefitinib and erlotinib. Proc Natl Acad Sci USA 2004; 101: 13306-11.
9. Shigematsu H, Lin L, Takahashi T et al. Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers. J Natl Cancer Inst 2005; 97: 339-46.
10. Tam IY, Chung LP, Suen WS et al. Distinct epidermal growth factor receptor and KRAS mutation patterns in non-small cell lung cancer patients with different tobacco exposure and clinicopathologic features. Clin Cancer Res 2006; 12: 1647-53.
11. Kato T, Ohgaki H, Hasegawa H et al. Carcinogenicity in rats of a mutagenic compound, 2-amino-3,8-dimethylimidazo[4,5-f] quinoxaline. Carcinogenesis 1988; 9: 71-3.
12. Kawano R, Takeshima Y, Inai K. Effects of K-ras gene mutations in the development of lung lesions induced by 4-(N-methyl-n-nitrosamino)-1-(3-pyridyl)-1-butanone in A/J mice. Jpn J Cancer Res 1996; 87: 44-50.
13. Kitada H, Tsutsumi M, Tsujiuchi T et al. Frequent mutations of Ki-ras but no mutations of Ha-ras and p53 in lung lesions induced by N-nitrosobis(2-hydroxypropyl)amine in rats. Mol Carcinog 1996; 15: 276-83.
14. Konishi Y, Kondo H, Denda A, Takahashi S, Inui S. Lung carcinomas induced by oral administration of N-bis(2-hydroxypropyl)nitrosamine in rats. In: Severi L, ed. Tumors of Early Life in Man and Animals. Perugia, Italy: Perugia University Press, 1978; 637-49.
15. Oghiso Y, Yamada Y. Comparisons of pulmonary carcinogenesis in rats following inhalation exposure to plutonium dioxide or X-ray irradiation. J Radiat Res (Tokyo) 2003; 44: 261-70.
16. Orita M, Iwahana H, Kanazawa H, Hayashi K, Sekiya T. Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms. Proc Natl Acad Sci USA 1989; 86: 2766-70.
17. Yuan J, Yeasky TM, Rhee MC, Glazer PM. Frequent T:A→G:C transversions in X-irradiated mouse cells. Carcinogenesis 1995; 16: 83-8.
18. Kimchi-Sarfaty C, Oh JM, Kim IW et al. A 'silent'polymorphism in the MDR1 gene changes substrate specificity. Science 2007; 315: 525-8.
19. Takano T, Ohe Y, Sakamoto H, Tsuta K et al. Epidermal growth factor receptor gene mutations and increased copy numbers predict gefitinib sensitivity in patients with recurrent non-small-cell lung cancer. J Clin Oncol 2005; 23: 6829-37.
20. Oghiso Y, Yamada Y. Immunohistochemical study on cellular origins of rat lung tumors induced by inhalation exposures to plutonium dioxide aerosols as compared to those by X-ray irradiation. J Radiat Res (Tokyo) 2002; 43: 301-11.
21. Ikeda S, Takabe K, Inagaki M, Funakoshi N, Suzuki K, Shibata T. Correlation between EGFR gene mutation pattern and Akt phosphorylation in pulmonary adenocarcinomas. Pathol Int 2007; 57: 268-75.
22. Nikula KJ, Snipes MB, Barr EB et al. Comparative pulmonary toxicities and carcinogenicities of chronically inhaled diesel exhaust and carbon black in F344 rats. Fundam Appl Toxicol 1995; 25: 80-94.
23. Ashakumary L, Vijayammal PL. Effect of nicotine on antioxidant defence mechanisms in rats fed a high-fat diet. Pharmacology 1996; 52: 153-8.
24. Bartsch H, Nair J. Chronic inflammation and oxidative stress in the genesis and perpetuation of cancer: Role of lipid peroxidation, DNA damage, and repair. Langenbecks Arch Surg 2006; 391: 499-510.
25. Politi K, Zakowski MF, Fan PD, Schonfeld EA, Pao W, Varmus HE. Lung adenocarcinomas induced in mice by mutant EGF receptors found in human lung cancers respond to a tyrosine kinase inhibitor or to down-regulation of the receptors. Genes Dev 2006; 20: 1496-510.